Rocket Pharmaceuticals
RCKT
RCKT
182 hedge funds and large institutions have $323M invested in Rocket Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 71 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.2% less ownership
Funds ownership: 89.51% → 84.31% (-5.2%)
17% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 71
Holders
182
Holding in Top 10
2
Calls
$325K
Puts
$191K
Top Buyers
| 1 | +$17.9M | |
| 2 | +$5.66M | |
| 3 | +$3.27M | |
| 4 |
BlackRock
New York
|
+$2.71M |
| 5 |
Two Sigma Investments
New York
|
+$1.79M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$7.93M | |
| 3 | -$6.11M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.13M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$2.91M |
